TOMSK, RUSSIA / RankWire.AI / – Russian scientists have evaluated a bioactive coating aimed at enhancing the interaction between titanium orthopedic implants and bone tissue. This innovative material incorporates calcium phosphate derived from hydroxyapatite and includes nitrogen compounds linked to nitric oxide production. Laboratory experiments demonstrated a notably higher survival rate of human mesenchymal stem cells on surfaces coated with this material compared to uncoated titanium. The team analyzed the coating’s structure, chemical makeup, mechanical properties, and biological effects. Their peer-reviewed results appeared in Applied Surface Science in 2026.
The scientists at Tomsk Polytechnic University created the experimental coatings by applying reactive magnetron sputtering of a hydroxyapatite target within a vacuum chamber. They manipulated the nitrogen and argon gas mixture during the process to observe how each variation affected the surface. Five different conditions were tested, spanning from pure nitrogen to pure argon. The researchers measured coating thickness, surface morphology, hardness, wettability, and chemical composition. They also performed laboratory tests to evaluate how living human cells reacted to the modified titanium surfaces.
The results indicated that the argon level influenced several physical characteristics of the coatings. Surfaces produced with pure argon were found to be denser and harder than those formed with pure nitrogen. Additionally, the coating thickness increased as the argon proportion grew. Chemical analysis revealed nitrogen-carbon and nitrogen-oxygen bonds on the modified surfaces. The team then compared the response of human mesenchymal stem cells grown on coated titanium with cells on uncoated titanium. The biological assessments focused on cell viability and markers associated with bone cell development.
Enhanced Coating Promotes Better Cell Survival in Laboratory Tests
According to the research findings, cell experiments showed significantly improved survival rates on coated surfaces versus uncoated titanium. After seven days, coatings with higher nitrogen levels also reduced activity in specific genes linked to early bone-cell differentiation. Despite this gene activity change, the cells maintained their ability to form bone tissue. The study was conducted under controlled laboratory conditions using human mesenchymal stem cells. It did not involve testing the coating in patients nor assessing the clinical performance of implanted medical devices.
The biomedical evaluation of the material was carried out by researchers from Immanuel Kant Baltic Federal University and Siberian State Medical University. The project also involved specialists from Saint Petersburg State University. Funding was provided through Russia’s national science program. The scientists aimed to identify gas mixtures that could produce optimal physical, chemical, and biological properties in the coatings. Hydroxyapatite is already used in implant coatings because its calcium phosphate composition closely resembles the mineral found in human bone.
The Study Remains at a Laboratory Testing Phase
The research team has outlined plans for further testing beyond the initial seven-day cell experiments. They intend to analyze stem cell responses over periods ranging from 10 to 28 days. Additionally, they plan to investigate how quickly the coatings dissolve and to measure nitric oxide release into surrounding tissue in living organisms. These future studies were not part of the published laboratory results. Currently, the research focuses on coated titanium substrates, their material properties, and in vitro cell reactions, rather than on clinical outcomes in orthopedic patients.
The data obtained provides detailed insights into how variations in nitrogen and argon ratios influence calcium phosphate coatings on titanium surfaces. The team documented differences in coating thickness, density, hardness, chemical bonds, and cellular responses across different gas mixtures. Their work also demonstrated that coated samples supported higher stem-cell survival than uncoated titanium under the experimental conditions. Nonetheless, the research remains at a preclinical stage, and the published experiments do not confirm safety or effectiveness in human patients. Additional biological testing will be necessary to evaluate properties not addressed in the current study.